logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
K

Kazuto Nishio

department of genome biology

81H指数
1.1K论文数
2.2W被引数
收录论文 300
发表时间
logo
Intratumoral heterogeneity of intermediate CLDN18.2 expression in gastric cancer胃癌中CLDN18.2中等表达的原位异质性
errInternational Journal of Clinical Oncology
IF2.8
err2026-07-07
err0
errOAAI
errYusuke Kawanaka; Chiaki Inagaki; Masaki Okura; Seiichiro Mitani; Naoki Shiraishi; Kazuko Sakai; Kazuto Nishio; Yutaka Kimura; Yasutaka Chiba; Tomoko Wakasa; Hisato Kawakami; Hidetoshi Hayashi
err分享
err收藏
Clonal Complexity Defines Distinct Tumor-Intrinsic Biology and Prognosis in Diffuse Large B-Cell Lymphoma
errCancer Medicine
IF3.1
err2026-02-02
err0
errOAAI
errTakahiro Haeno; Kazuko Sakai; Shuji Minamoto; Daiki Nakatsu; Marco A. De Velasco; Shinya Rai; Hirokazu Tanaka; Itaru Matsumura; Kazuto Nishio
err分享
err收藏
Zongertinib, a Novel HER2 Tyrosine Kinase Inhibitor, Maintains an Anticancer Activity for Trastuzumab Deruxtecan-Resistant Cancers Harboring HER2-OverexpressionZongertinib，一种新型HER2酪氨酸激酶抑制剂，对HER2过表达的曲妥珠单抗德鲁替康耐药癌具有抗癌活性。
errInternational Journal of Molecular Sciences 2025, Vol. 26, Page 10515
IF4.9
err2025-10-29
err0
errOAAI
errTakashi Kurosaki; Shinichiro Suzuki; Kimio Yonesaka; Yusuke Kawanaka; Toshiyuki Takehara; Takeshi Teramura; Kazuko Sakai; Kazuto Nishio; Hidetoshi Hayashi
err分享
err收藏
Cure of Recurrent Ovarian Cancer: A Multicenter Retrospective Study复发性卵巢癌的治疗：一项多中心回顾性研究
errCancers 2025, Vol. 17, Page 3069
IF0
err2025-09-23
err0
errOAAI
errMasahiro Sumitomo; Yasushi Kotani; Kosuke Murakami; Kaoru Abiko; Kazuko Sakai; Tomoyuki Otani; Akihiko Ueda; Masayo Ukita; Atsuko Taga; Ikuko Emoto; Kentaro Sekiyama; Minami Okudate; Motonori Matsubara; Yukio Yamanishi; Kazuto Nishio; Masaki Mandai; Noriomi Matsumura
err分享
err收藏
Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations—An In Vitro Study传统和新型酪氨酸激酶抑制剂对罕见EGFR突变的疗效——一项体外研究
errCells 2025, Vol. 14, Page 1386
IF5.2
err2025-09-20
err0
errOAAI
errHana Oiki; Kenichi Suda; Akira Hamada; Toshio Fujino; Keiko Obata; Yoshihisa Kobayashi; Kazuko Sakai; Shota Fukuda; Shuta Ohara; Masaoki Ito; Junichi Soh; Kazuto Nishio; Tetsuya Mitsudomi; Yasuhiro Tsutani
err分享
err收藏
Biological impact of chemotherapy during treatment with EGFR tyrosine kinase inhibitors for non-small cell lung cancer positive for EGFR activating mutationsEGFR激活突变阳性的非小细胞肺癌患者在接受EGFR酪氨酸激酶抑制剂治疗期间化疗的生物学影响
errLung Cancer
IF4.4
err2025-09-16
err0
errOAAI
errEiji Iwama; Kazuko Sakai; Taishi Harada; Shintaro Kanda; Shunichi Sugawara; Toshihide Yokoyama; Hirokazu Taniguchi; Kaoru Tanaka; Ryo Toyozawa; Kenichi Koyama; Yoshitaka Zenke; Gen Kida; Yasuhiko Nishioka; Hiroshi Yokouchi; Masayuki Hirose; Kazuto Nishio; Nobuyuki Yamamoto; Yuichiro Ohe; Isamu Okamoto
err分享
err收藏
RELAY: safety and efficacy of ramucirumab plus erlotinib in elderly Japanese patients with metastatic EGFR-mutated NSCLCRELAY研究：雷莫芦单抗联合厄洛替尼在老年日本患者中针对转移性EGFR突变非小细胞肺癌的安全性与有效性
errFUTURE ONCOLOGY
IF2.6
err2025-09-01
err0
PREAI
errNishino, Kazumi; Seto, Takashi; Nishio, Makoto; Nishio, Kazuto; Kasahara, Kazuo; Satouchi, Miyako; Yoh, Kiyotaka; Hayashi, Hidetoshi; Enatsu, Sotaro; Matsui, Tomoko; Varughese, Sunoj Chacko; Visseren-Grul, Carla; Nakagawa, Kazuhiko
err分享
err收藏
Impact of B7-H3 and DLL3 expression on the efficacy of PD-L1 blockade therapy in extensive-stage small cell lung cancerB7-H3和DLL3表达对广泛期小细胞肺癌中PD-L1阻断疗法疗效的影响
errLung Cancer
IF4.4
err2025-08-23
err0
PREAI
errTakashi Kurosaki; Hiroaki Kanemura; Tomoyuki Otani; Yusuke Kawanaka; Yasushi Fukuda; Keita Kudo; Junko Tanizaki; Shinichiro Suzuki; Shuta Tomida; Kazuko Sakai; Yasutaka Chiba; Akihiko Ito; Kazuto Nishio; Kazuhiko Nakagawa; Hidetoshi Hayashi
err分享
err收藏
A phase II study of afatinib in combination with pemetrexed and carboplatin in patients with EGFR mutation-positive non-squamous, advanced non-small cell lung cancer (NSCLC) refractory to first-line osimertinib treatment: NEJ025B Study一项关于阿法替尼与培美曲塞和卡铂联合治疗EGFR突变阳性、非鳞状、晚期非小细胞肺癌（NSCLC）患者（对一线奥希替尼治疗耐药）的II期研究：NEJ025B研究
errEuropean Journal of Cancer
IF7.1
err2025-08-20
err0
PREAI
errHiromi Nagashima; Tatsuro Fukuhara; Yu Utsumi; Aya Suzuki; Akihiko Miyanaga; Masahiro Seike; Koichi Azuma; Hajime Asahina; Akira Kisohara; Yosuke Kawashima; Hisashi Tanaka; Ryota Kanemaru; Eisaku Miyauchi; Naoki Furuya; Haruna Sato; Kazuhisa Nakashima; Satoshi Watanabe; Kazuko Sakai; Kazuto Nishio; Fumiaki Takahashi; Kunihiko Kobayashi; Makoto Maemondo
err分享
err收藏
Exploration of genes related to the development of cancer of unknown primary未知原发灶癌症发生相关基因的探索
errONCOLOGY REPORTS
IF3.9
err2025-04-30
err0
PREAI
errFujita, Yoshihiko; De Velasco, Marco A.; Hayashi, Hidetoshi; Nakagawa, Kazuhiko; Nishio, Kazuto
err分享
err收藏
Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC: RELAY Japanese Subset拉姆昔利单抗联合厄洛替尼对比安慰剂联合厄洛替尼，用于未治EGFR突变型转移性非小细胞肺癌患者的最终生存结局：RELAY日本亚组
errJTO CLINICAL AND RESEARCH REPORTS
IF3.5
err2025-02-01
err0
errOAAI
errNishio, Makoto; Seto, Takashi; Reck, Martin; Garon, Edward B.; Nishio, Kazuto; Kasahara, Kazuo; Nishino, Kazumi; Satouchi, Miyako; Yoh, Kiyotaka; Hayashi, Hidetoshi; Sakai, Kazuko; Enatsu, Sotaro; Frimodt-Moller, Bente; Matsui, Tomoko; Varughese, Sunoj Chacko; Carlsen, Michelle; Visseren-Grul, Carla; Nakagawa, Kazuhiko
err分享
err收藏
Final Analysis Data and Exploratory Biomarker Analysis of a Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib Monotherapy for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: The WJOG9717L Study
errJTO CLINICAL AND RESEARCH REPORTS
IF3.5
err2024-11-01
err1
errOAAI
errKenmotsu, Hirotsugu; Sakai, Kazuko; Mori, Keita; Kato, Terufumi; Sugawara, Shunichi; Kirita, Keisuke; Yoneshima, Yasuto; Azuma, Koichi; Nishino, Kazumi; Teraoka, Shunsuke; Koyama, Ryo; Masuda, Ken; Hayashi, Hidetoshi; Toyozawa, Ryo; Miura, Satoru; Sato, Yuki; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki; Nishio, Kazuto; Takahashi, Toshiaki
err分享
err收藏
Update analysis of the randomized phase II study comparing FOLFIRI plus ramucirumab (RAM) versus FOLFOXIRI plus RAM as first-line treatment for patients with metastatic colorectal cancer: WJOG9216G (RECAST)对比较FOLFIRI联合ramucirumab（RAM）与FOLFOXIRI联合RAM作为转移性结直肠癌患者一线治疗的随机II期研究的更新分析：WJOG9216G（RECAST）
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errYamazaki, K.; Kito, Y.; Shoji, H.; Yamada, T.; Tsushima, T.; Mitani, S.; Shiraishi, K.; Yasui, H.; Hara, H.; Shimozaki, K.; Esaki, T.; Shinohara, Y.; Tsuzuki, T.; Kajiura, S.; Yoshimura, K.; Sakai, K.; Nishio, K.; Kawakami, H.; Hironaka, S.; Muro, K.
err分享
err收藏
Exploring the relationship between ulcerative colitis, colorectal cancer, and prostate cancer溃疡性结肠炎与结直肠癌、前列腺癌关系的探讨
errHUMAN CELL
IF3.1
err2024-08-20
err1
PREAI
errKura, Yurie; De Velasco, Marco A.; Sakai, Kazuko; Uemura, Hirotsugu; Fujita, Kazutoshi; Nishio, Kazuto
err分享
err收藏
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade
errJOURNAL OF CLINICAL INVESTIGATION
IF13.6
err2024-04-01
err3
errOAAI
errHayashi, Hidetoshi; Chamoto, Kenji; Hatae, Ryusuke; Kurosaki, Takashi; Togashi, Yosuke; Fukuoka, Kazuya; Coto, Megumi; Chiba, Yasutaka; Tomida, Shuta; Ota, Takayo; Haratani, Koji; Takahama, Takayuki; Tanizaki, Junko; Yoshida, Takeshi; Iwasa, Tsutomu; Tanaka, Kaoru; Takeda, Masayuki; Hirano, Tomoko; Yoshida, Hironori; Ozasa, Hiroaki; Sakamori, Yuichi; Sakai, Kazuko; Higuchi, Keiko; Uga, Hitoshi; Suminaka, Chihiro; Hirai, Toyohiro; Nishio, Kazuto; Nakagawa, Kazuhiko; Honjo, Tasuku
err分享
err收藏
The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma肿瘤免疫微环境与早期肺腺癌复发相关
errJTO CLINICAL AND RESEARCH REPORTS
IF3.5
err2024-04-01
err3
errOAAI
errKanemura, Hiroaki; Yokoyama, Toshihide; Nakajima, Ryu; Nakamura, Atsushi; Kuroda, Hiroaki; Kitamura, Yoshitaka; Shoda, Hiroyasu; Mamesaya, Nobuaki; Miyata, Yoshihiro; Okamoto, Tatsuro; Okishio, Kyoichi; Oki, Masahide; Sakairi, Yuichi; Chen-Yoshikawa, Toyofumi Fengshi; Aoki, Tadashi; Ohira, Tatsuo; Matsumoto, Isao; Ueno, Kiyonobu; Miyazaki, Takuro; Matsuguma, Haruhisa; Yokouchi, Hideoki; Otani, Tomoyuki; Ito, Akihiko; Sakai, Kazuko; Chiba, Yasutaka; Nishio, Kazuto; Yamamoto, Nobuyuki; Okamoto, Isamu; Nakagawa, Kazuhiko; Takeda, Masayuki
err分享
err收藏
Identification and characterization of cancer-associated polymorphonuclear cell subsets in mice
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errDe Velasco, Marco A.; Kura, Yurie; Sakai, Kazuko; Kikuchi, Takashi; Mori, Yasunori; Minami, Takafumi; Yoshimura, Kazuhiro; Fujita, Kazutoshi; Nishio, Kazuto; Uemura, Hirotsugu
err分享
err收藏
Comprehensive protein analysis to identify the proteins responsible for sarcopenia and their impact on antitumor immunotherapy in non-small cell lung cancer
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errMasuda, Takaaki; Watanabe, Satoshi; Wakabayashi, Tomoya; Tanaka, Susumu; Shono, Kunihiro; Suzuki, Ryo; Sekiya, Tomoki; Yanagimura, Naohiro; Arita, Masashi; Ohtsubo, Aya; Tanaka, Tomohiro; Nozaki, Koichiro; Saida, Yu; Hokari, Satoshi; Kondo, Rie; Shima, Kenjiro; Kimura, Yosuke; Aoki, Nobumasa; Ohshima, Yasuyoshi; Koya, Toshiyuki; Sakai, Kazuko; Nishio, Kazuto; Yamazaki, Motohiko; Ishikawa, Hiroyuki; Kikuchi, Toshiaki
err分享
err收藏
Profiling peripheral blood to predict response to targeted androgen receptor axis therapy in mice
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errDe Velasco, Marco A.; Kura, Yurie; Sakai, Kazuko; Saito, Yoshitaka; Minami, Takafumi; Yoshimura, Kazuhiro; Fujita, Kazutoshi; Nishio, Kazuto; Uemura, Hirotsugu
err分享
err收藏
Machine learning-based classification of tissue origin of cancer using methylation profiles
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errDe Velasco, Marco A.; Sskai, Kazuko; Mitani, Seiichiro; Kura, Yurie; Minamoto, Shuji; Haeno, Takahiro; Hayashi, Hidetoshi; Nishio, Kazuto
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
P
Pasi A. Jänne
H 指数: 163 · 论文数: 2.3K
T
Tasuku Honjo
H 指数: 143 · 论文数: 737
M
Masatoshi Kudo
H 指数: 143 · 论文数: 2.8K
J
Jeffrey A. Engelman
H 指数: 131 · 论文数: 874
T
Tetsuya Mitsudomi
H 指数: 113 · 论文数: 1.0K
查看更多